Synergistic effect of fosfomycin and arbekacin on a methicillin-resistant Staphylococcus aureus-induced biofilm in a rat model

International Journal of Antimicrobial Agents

Volumn 25, Issue 1, 2005, Pages 44-50

  Morikawa, Keiko ^a   Nonaka, Mitsuko ^a   Yoshikawa, Yuka ^a   Torii, Ikuko ^b  

^a SAGAMI WOMEN'S UNIVERSITY   (Japan)

^b SHIMANE UNIVERSITY   (Japan)

Author keywords

Air pouch; Antibiotics; Biofilm; MRSA

Indexed keywords

ANTIBIOTIC AGENT; FOSFOMYCIN; HABEKACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; BIOFILM; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EXUDATE; HISTOCHEMISTRY; INFLAMMATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROMORPHOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS;

AMINOGLYCOSIDES; ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; DIBEKACIN; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; FOSFOMYCIN; GRANULOMA; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 11144255295     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2004.07.015     Document Type: Article

References (29)

1. M. Dunne Jr., E.O. Mason Jr., and S.L. Kaplan Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm Antimicrob Agents Chemother 37 1993 2522 2526
2. N.R. Stanley, and A. Lazazzera Environmental signals and regulatory pathways that influence biofilm formation Mol Microbiol 52 2004 917 924 [mini review]
3. H. Yasuda, T. Koga, and T. Fukuda In vitro and in vivo models of bacterial biofilms Methods Enzymol 310 1999 577 584
4. J.L. Wallace, K. Chapman, and W. Mc Knight Limited anti-inflammatory efficacy of cyclooxygenase-2 inhibition in carrageenin-air pouch inflammation Br J Pharmacol 126 1999 1200 1204
5. E. Brauner, S. Gorbach, and P. Davey Comparative study of clindamycin, impenem, oxacillin and vancomycin in the infected granuloma pouch model J Antimicrob Chemother 23 1989 891 898
6. H. Yasuda, Y. Ajiki, and T. Koga Interaction between biofilm formed by Pseudomonas aeruginosa and clarithromycin Antimicrob Agent Chemother 37 1993 1749 1755
7. Yoshikawa Y, Morikawa K, Nonaka M, et al. Effect of arbekacin on a methicillin-resistant staphylococcus aureus-induced biofilm in a rat model. J Infect Chemother, in press.
8. K. Morikawa, H. Watanabe, and M. Araake Modulatory effect of antibiotics on cytokine production by human monocytes in vitro Antimicrob Agents Chemother 40 1996 1366 1370
9. K. Morikawa, J. Zang, and M. Nonaka Modulatory effect of macrolide antibiotics on the Th1- and Th2-type cytokine production Int J Antimicrob Agents 19 2002 53 59
10. T. Matsumoto, K. Tateda, and S. Miyazaki Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice Antimicrob Agents Chemother 43 1999 697 698
11. M. Inoue, M. Nonoyama, and R. Okamoto Antimicrobial activity of arbekacin, a new amynoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus Drugs Exp Clin Res 20 1994 233 239
12. I. Hayashi, M. Inoue, and H. Hashimoto Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections Drugs Exp Clin Res 20 1994 225 232
13. N. Tanaka, K. Matsunaga, and A. Hirata Mechanism of action of arbekacin, a novel amino acid-containing aminoglycoside antibiotic Antimicrob Agents Chemother 24 1983 797 802
14. P.M. Kahan, J.S. Kahan, and P.J. Cassidy The mechanism of action of fosfomycin (phosphomycin) Ann NY Acad Sci 235 1974 364 386
15. K. Morikawa, F. Oseko, and S. Morikawa Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro Antimicrob Agents Chemother 37 1993 2684 2687
16. F. Gotz Staphylococcus and biofilms Mol Microbiol 43 2002 1367 1378 [micro reviews]
17. Y.J. Miyamoto, E.R. Wann, and T. Fowler Fibronectin binding protein A of Staphylococcus aureus can mediate human T lymphocyte adhesion and coactivation J Immunol 166 2001 5129 5138
18. S. Phillip, and C.J. William Antibiotic resistance of bacteria in biofilm Lancet 358 2001 135 138
19. K. Morikawa, I. Torii, and S. Morikawa Immunomodulatory activity of fosfomycin Recent Res Develop Antimicrob Agents Chemother 3 1999 371 381
20. K. Morikawa, F. Oseko, and S. Morikawa Immunomodulatory effect of fosfomycin on human B-lymphocyte function in vitro Antimicrob Agents Chemother 37 1993 270 275
21. J. Honda, Y. Okubo, and M. Kusaba Fosfomycin (FOM: 1R-2S- epoxypropylphosphonic acid) suppress the production of IL-8 from monocytes via the suppression of neutrophil function Immunopharmacology 39 1998 149 155
22. K. Morikawa, M. Nonaka, and I. Torii Modulatory effect of fosfomycin on acute inflammation in the rat air pouch model Int J Antimicrob Agents 21 2003 334 339
23. M. Hamada, J. Honda, and T. Yoshimuta Fosfomycin inhibits neutrophil function via a protein kinase C-dependent signaling pathway Int J Immunopharmacol 2 2002 511 518
24. Y. Yoneshima, T. Ichikawa, and H. Ayukawa Fosfomycin inhibits NF-kB activation in U-937 and Jurkat cells Int J Antimicrob Agents 21 2003 589 592
25. H. Kumon, N. Ono, and M. Iida Combination effect of fosfomycin and ofloxacin against Pseudomonas aeruginosa growing in a biofilm Antimicrob Agents Chemother 39 1995 1038 1044
26. J.I. Guangyong, R.C. Beavis, and R.P. Novick Cell density control of staphylococcal virulence mediated by an octapeptide pheromone Proc Natl Acad Sci USA 92 1995 12055 12059
27. K. Tateda, R. Comte, and J.-C. Pechere Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa Antimicrob Agents Chemother 45 2001 1930 1933
28. K. Bernardo, N. Pakulat, and S. Fleer Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression Antimicrob Agents Chemother 48 2004 546 555
29. S. Inouye, T. Niizato, and I. Komiya Mode of protective action of fosfomycin against dibekacin-induced nephrotoxicity in the dehydrated rats J Pharmacobiodyn 5 1982 941 950